[
  {
    "ts": null,
    "headline": "Gilead Sciences to Present at Upcoming Investor Conferences",
    "summary": "FOSTER CITY, Calif., April 29, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:",
    "url": "https://finnhub.io/api/news?id=a2f63154d17f6b3fab02468eab4d1cc1184df1c3ac58f80e06a298325d5838f4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745957100,
      "headline": "Gilead Sciences to Present at Upcoming Investor Conferences",
      "id": 134141762,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "FOSTER CITY, Calif., April 29, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:",
      "url": "https://finnhub.io/api/news?id=a2f63154d17f6b3fab02468eab4d1cc1184df1c3ac58f80e06a298325d5838f4"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Gain Late Afternoon",
    "summary": "Health care stocks were rising late Tuesday afternoon, with the NYSE Health Care Index adding 1.2% a",
    "url": "https://finnhub.io/api/news?id=4bd9038aacf5265a711f8768f84e69e388d701798dca3f39e27ab97d81ecb3e7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745956812,
      "headline": "Sector Update: Health Care Stocks Gain Late Afternoon",
      "id": 134141763,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Health care stocks were rising late Tuesday afternoon, with the NYSE Health Care Index adding 1.2% a",
      "url": "https://finnhub.io/api/news?id=4bd9038aacf5265a711f8768f84e69e388d701798dca3f39e27ab97d81ecb3e7"
    }
  },
  {
    "ts": null,
    "headline": "Update: Gilead Sciences to Pay $202 Million in Settlement of Illegal Kickbacks Lawsuit",
    "summary": "(Updates with company statement in the fifth and sixth paragraphs.) Gilead Sciences (GILD) has ag",
    "url": "https://finnhub.io/api/news?id=9fb80e6344ad53d2af6db864f5890001930cc77bdddf4d4c88238d334f4fde95",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745952362,
      "headline": "Update: Gilead Sciences to Pay $202 Million in Settlement of Illegal Kickbacks Lawsuit",
      "id": 134141764,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "(Updates with company statement in the fifth and sixth paragraphs.) Gilead Sciences (GILD) has ag",
      "url": "https://finnhub.io/api/news?id=9fb80e6344ad53d2af6db864f5890001930cc77bdddf4d4c88238d334f4fde95"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences (NasdaqGS:GILD) Showcases Promising Liver Disease Treatments At EASL Congress",
    "summary": "Gilead Sciences (NasdaqGS:GILD) recently announced a presentation at the EASL Congress focusing on liver disease, with promising research in both hepatitis B and C. This comes alongside solid Q1 earnings results where a significant net income turnaround was noted. These developments, combined with a quarterly dividend declaration and ongoing share buybacks, potentially supported a 13% share price increase over the last quarter. Meanwhile, the general market showed strength with a 7% rise,...",
    "url": "https://finnhub.io/api/news?id=c51735a1366be8f35be5da5e532bd5e6c90af903d2601aacb58c03f493a641d4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745947636,
      "headline": "Gilead Sciences (NasdaqGS:GILD) Showcases Promising Liver Disease Treatments At EASL Congress",
      "id": 134141765,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences (NasdaqGS:GILD) recently announced a presentation at the EASL Congress focusing on liver disease, with promising research in both hepatitis B and C. This comes alongside solid Q1 earnings results where a significant net income turnaround was noted. These developments, combined with a quarterly dividend declaration and ongoing share buybacks, potentially supported a 13% share price increase over the last quarter. Meanwhile, the general market showed strength with a 7% rise,...",
      "url": "https://finnhub.io/api/news?id=c51735a1366be8f35be5da5e532bd5e6c90af903d2601aacb58c03f493a641d4"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences Inc. stock underperforms Tuesday when compared to competitors",
    "summary": "Gilead Sciences Inc. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=ee8f7c5b9d569bf2b4a0868b5e5a1f61ac183b6983ef102b92567f93e2296efb",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745944560,
      "headline": "Gilead Sciences Inc. stock underperforms Tuesday when compared to competitors",
      "id": 134149018,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Sciences Inc. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=ee8f7c5b9d569bf2b4a0868b5e5a1f61ac183b6983ef102b92567f93e2296efb"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : Gilead Sciences, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 11",
    "summary": "Presenter SpeechUnknown Analyst [Audio Gap]QuestionUnknown Analyst You'll love to answer. So high-level question just to begin with, which is New headlines every day, it seems like MSM most",
    "url": "https://finnhub.io/api/news?id=2f7502a0199860608108e0730d986436ee74bc140591655e85b59be2e6c20047",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745942700,
      "headline": "Transcript : Gilead Sciences, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 11",
      "id": 134415541,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "Presenter SpeechUnknown Analyst [Audio Gap]QuestionUnknown Analyst You'll love to answer. So high-level question just to begin with, which is New headlines every day, it seems like MSM most",
      "url": "https://finnhub.io/api/news?id=2f7502a0199860608108e0730d986436ee74bc140591655e85b59be2e6c20047"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences to pay $202 million in US settlement over HIV drug kickbacks",
    "summary": "NEW YORK -Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying kickbacks to doctors who agreed to prescribe its HIV drugs. ...",
    "url": "https://finnhub.io/api/news?id=566b691e2d090f7a07feaa7dcc1bb7bb1469d3d764f78c6ea56053c18c641615",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745937084,
      "headline": "Gilead Sciences to pay $202 million in US settlement over HIV drug kickbacks",
      "id": 134134848,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "NEW YORK -Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying kickbacks to doctors who agreed to prescribe its HIV drugs. ...",
      "url": "https://finnhub.io/api/news?id=566b691e2d090f7a07feaa7dcc1bb7bb1469d3d764f78c6ea56053c18c641615"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences : Statement on Settlement Agreement with U.S. Department of Justice Resolving Legacy Compliance Matter",
    "summary": "Foster City, Calif., April 29, 2025 - Gilead Sciences has reached an agreement resolving a civil investigation by the U.S. Attorney's Office for the Southern District of New York concerning the...",
    "url": "https://finnhub.io/api/news?id=ee843820413571dfaa0c883bec2dda52a6643df3dd1ef376df7090cddd71fdb8",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745935267,
      "headline": "Gilead Sciences : Statement on Settlement Agreement with U.S. Department of Justice Resolving Legacy Compliance Matter",
      "id": 134134647,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "Foster City, Calif., April 29, 2025 - Gilead Sciences has reached an agreement resolving a civil investigation by the U.S. Attorney's Office for the Southern District of New York concerning the...",
      "url": "https://finnhub.io/api/news?id=ee843820413571dfaa0c883bec2dda52a6643df3dd1ef376df7090cddd71fdb8"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences reaches $202 million settlement with US over kickbacks to doctors",
    "summary": "NEW YORK -Gilead Sciences has reached a $202 million settlement to resolve a civil fraud lawsuit accusing the company of paying kickbacks to doctors who agreed to prescribe its HIV drugs, the U.S....",
    "url": "https://finnhub.io/api/news?id=14240d81234b2a5ed960b7a69917450dbcf431524b62e1f2df33f7ff567ff1b9",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745934741,
      "headline": "Gilead Sciences reaches $202 million settlement with US over kickbacks to doctors",
      "id": 134134399,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "NEW YORK -Gilead Sciences has reached a $202 million settlement to resolve a civil fraud lawsuit accusing the company of paying kickbacks to doctors who agreed to prescribe its HIV drugs, the U.S....",
      "url": "https://finnhub.io/api/news?id=14240d81234b2a5ed960b7a69917450dbcf431524b62e1f2df33f7ff567ff1b9"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences: AIDSVu Online Mapping Tool Helps Visualize HIV’s Impact in the United States",
    "summary": "NORTHAMPTON, MA / ACCESS Newswire / April 29, 2025 / Gilead is committed to using its virology expertise to advance HIV treatment and prevention to help end the epidemic. Since 2010, the company has partnered with Emory University in Atlanta to launch ...",
    "url": "https://finnhub.io/api/news?id=9b595518a417aaf260fa0f16b63bbcdf56d96484400f64106985b042bdbd9fa1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745930100,
      "headline": "Gilead Sciences: AIDSVu Online Mapping Tool Helps Visualize HIV’s Impact in the United States",
      "id": 134131229,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "NORTHAMPTON, MA / ACCESS Newswire / April 29, 2025 / Gilead is committed to using its virology expertise to advance HIV treatment and prevention to help end the epidemic. Since 2010, the company has partnered with Emory University in Atlanta to launch ...",
      "url": "https://finnhub.io/api/news?id=9b595518a417aaf260fa0f16b63bbcdf56d96484400f64106985b042bdbd9fa1"
    }
  },
  {
    "ts": null,
    "headline": "Gilead to Present Latest Advancements Across Primary Biliary Cholangitis and Viral Hepatitis",
    "summary": "FOSTER CITY, Calif., April 29, 2025--Gilead Sciences, Inc. (Nasdaq:GILD) today announced new research to be presented at the European Association for the Study of the Liver (EASL) Congress, May 7-10, 2025, Amsterdam, furthering Gilead’s commitment to transform the lives of people living with liver disease.",
    "url": "https://finnhub.io/api/news?id=9820fde16e18b7884fd2cd0fbceca8059ba2bcda7f1ad9ce7ae731284d512966",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745929800,
      "headline": "Gilead to Present Latest Advancements Across Primary Biliary Cholangitis and Viral Hepatitis",
      "id": 134131230,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "FOSTER CITY, Calif., April 29, 2025--Gilead Sciences, Inc. (Nasdaq:GILD) today announced new research to be presented at the European Association for the Study of the Liver (EASL) Congress, May 7-10, 2025, Amsterdam, furthering Gilead’s commitment to transform the lives of people living with liver disease.",
      "url": "https://finnhub.io/api/news?id=9820fde16e18b7884fd2cd0fbceca8059ba2bcda7f1ad9ce7ae731284d512966"
    }
  }
]